Dietary regulation of adiponectin by direct and indirect lipid activators of nuclear hormone receptors

Molecular Nutrition and Food Research

Volumn 60, Issue 1, 2016, Pages 175-184

  Ruhl R ^a,b   Landrier, J F ^c,d,e  

^a Paprika Bioanalytics Bt   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c CEMAGREF   (France)

^d INSERM   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adiponectin; Adipose tissue; Ligand; Nuclear hormone receptor; Vitamins

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; CELL RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; RETINOL; UNSATURATED FATTY ACID; VITAMIN D; VITAMIN K GROUP;

ANIMAL; BLOOD; DIET; DISEASE MODEL; FISH; FRUIT; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; SEA FOOD; SECRETION (PROCESS); SIGNAL TRANSDUCTION; VEGETABLE;

ADIPONECTIN; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, UNSATURATED; FISHES; FRUIT; HUMANS; INSULIN RESISTANCE; PPAR GAMMA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS; SEAFOOD; SIGNAL TRANSDUCTION; VEGETABLES; VITAMIN A; VITAMIN D; VITAMIN E; VITAMIN K;

EID: 84952980640     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500619     Document Type: Review

References (103)

1. Gregor, M. F., Hotamisligil, G. S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415-445.
2. Tourniaire, F., Romier-Crouzet, B., Lee, J. H., Marcotorchino, J. et al., Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kappa B. PLoS One 2013, 8, e66515.
3. Ziemke, F., Mantzoros, C. S., Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 2010, 91, 258S-261S.
4. Lara-Castro, C., Fu, Y., Chung, B. H., Garvey, W. T., Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr. Opin. Lipidol. 2007, 18, 263-270.
5. Oh, D. K., Ciaraldi, T., Henry, R. R., Adiponectin in health and disease. Diabetes Obes. Metab. 2007, 9, 282-289.
6. Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H. et al., Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 2003, 278, 9073-9085.
7. Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W. et al., Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 2004, 279, 12152-12162.
8. Liu, M., Liu, F., Transcriptional and post-translational regulation of adiponectin. Biochem. J. 2009, 425, 41-52.
9. Turer, A. T., Scherer, P. E., Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012, 55, 2319-2326.
10. Andreasson, A. N., Unden, A. L., Elofsson, S., Brismar, K., Leptin and adiponectin: distribution and associations with cardiovascular risk factors in men and women of the general population. Am. J. Hum. Biol. 2012, 24, 595-601.
11. Turer, A. T., Khera, A., Ayers, C. R., Turer, C. B. et al., Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia 2011, 54, 2515-2524.
12. Matsuzawa, Y., The role of fat topology in the risk of disease. Int. J. Obes. 2008, 32(Suppl 7), S83-S92.
13. Michaud, A., Boulet, M. M., Veilleux, A., Noel, S. et al., Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism 2014, 63, 372-381.
14. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H. et al., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731-737.
15. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M. et al., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 2007, 13, 332-339.
16. Rosen, E. D., Spiegelman, B. M., Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444, 847-853.
17. Wijesekara, N., Krishnamurthy, M., Bhattacharjee, A., Suhail, A. et al., Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J. Biol. Chem. 2010, 285, 33623-33631.
18. Daval, M., Ferre, P., Foufelle, F., [AMPK, an active player in the control of metabolism]. J. Soc. Biol. 2006, 200, 99-105.
19. Liu, M., Liu, F., Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. Biochimie 2012, 94, 2126-2130.
20. Han, S. H., Quon, M. J., Kim, J. A., Koh, K. K., Adiponectin and cardiovascular disease: response to therapeutic interventions. J. Am. Coll. Cardiol. 2007, 49, 531-538.
21. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S. et al., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50, 2094-2099.
22. Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T. et al., Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52, 1655-1663.
23. Qiao, L., Maclean, P. S., Schaack, J., Orlicky, D. J. et al., C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005, 54, 1744-1754.
24. Farmer, S. R., Transcriptional control of adipocyte formation. Cell. Metab. 2006, 4, 263-273.
25. Tourniaire, F., Musinovic, H., Gouranton, E., Astier, J. et al., All-trans retinoic acid induces oxidative phosphorylation and mitochondria biogenesis in adipocytes. J. Lipid Res. 2015, 56, 1100-1109.
26. Rühl, R., Sczech, R., Landes, N., Pfluger, P. et al., Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane X receptor. Eur. J. Nutr. 2004, 43, 336-343.
27. Lorente-Cebrian, S., Eriksson, A., Dunlop, T., Mejhert, N. et al., Differential effects of 1alpha, 25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur. J. Nutr. 2012, 51, 335-342.
28. Houde, A. A., Legare, C., Hould, F. S., Lebel, S. et al., Cross-tissue comparisons of leptin and adiponectin: DNA methylation profiles. Adipocyte 2014, 3, 132-140.
29. Houde, A. A., Legare, C., Biron, S., Lescelleur, O. et al., Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women. BMC Med. Genet. 2015, 16, 29-39.
30. Rühl, R., Effects of dietary retinoids and carotenoids on immune development. Proc. Nutr. Soc. 2007, 66, 458-469.
31. Rühl, R., Bub, A., Watzl, B., Modulation of plasma all-trans retinoic acid concentrations by the consumption of carotenoid-rich vegetables. Nutrition 2008, 24, 1224-1226.
32. Tishinsky, J. M., Dyck, D. J., Robinson, L. E., Lifestyle factors increasing adiponectin synthesis and secretion. Vitam. Horm. 2012, 90, 1-30.
33. Lengqvist, J., Mata De Urquiza, A., Bergman, A. C., Willson, T. M. et al., Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics 2004, 3, 692-703.
34. de Urquiza, A. M., Liu, S., Sjoberg, M., Zetterstrom, R. H. et al., Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290, 2140-2144.
35. Goldstein, J. T., Dobrzyn, A., Clagett-Dame, M., Pike, J. W., DeLuca, H. F., Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch. Biochem. Biophys. 2003, 420, 185-193.
36. Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K. et al., International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006, 58, 726-741.
37. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I. et al., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83, 813-819.
38. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P. et al., 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995, 83, 803-812.
39. Buczynski, M. W., Dumlao, D. S., Dennis, E. A., Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid. Res 2009, 50, 1015-1038.
40. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. et al., Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93, 229-240.
41. Dozsa, A., Dezso, B., Toth, B. I., Bacsi, A. et al., PPARgamma-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes. J. Invest. Dermatol. 2014, 134, 910-920.
42. Shiraki, T., Kamiya, N., Shiki, S., Kodama, T. S. et al., Alpha, beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2005, 280, 14145-14153.
43. Rühl, R., Krzyzosiak, A., Niewiadomska-Cimicka, A., Rochel, N. et al., 9-cis-13, 14-Dihydroretinoic acid is an endogenous retinoid acting as rxr ligand in mice. PLoS Genet. 2015, 11, e1005213.
44. Aydemir, G., Carlsen, H., Blomhoff, R., Rühl, R., Lycopene induces retinoic acid receptor transcriptional activation in mice. Mol. Nutr. Food Res. 2012, 56, 702-712.
45. van den Berg, H., Effect of lutein on beta-carotene absorption and cleavage. Int. J. Vitam. Nutr. Res. 1998, 68, 360-365.
46. Landes, N., Pfluger, P., Kluth, D., Birringer, M. et al., Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 2003, 65, 269-273.
47. Landes, N., Birringer, M., Brigelius-Flohe, R., Homologous metabolic and gene activating routes for vitamins E and K. Mol. Aspects Med. 2003, 24, 337-344.
48. Landrier, J. F., Gouranton, E., El Yazidi, C., Malezet, C. et al., Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Endocrinology 2009, 150, 5318-5325.
49. Spruiell, K., Richardson, R. M., Cullen, J. M., Awumey, E. M. et al., Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J. Biol. Chem. 2013, 289, 3244-3261.
50. Matsunaga, T., Shoji, A., Gu, N., Joo, E. et al., gamma-Tocotrienol attenuates TNF-alpha-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol. Med. Rep. 2012, 5, 905-909.
51. Sutherland, W. H., Manning, P. J., Walker, R. J., de Jong, S. A. et al., Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity 2007, 15, 386-391.
52. Balmer, M. L., Siegrist, K., Zimmermann, A., Dufour, J. F., Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver Int. 2009, 29, 1184-1188.
53. Costacou, T., Ma, B., King, I. B., Mayer-Davis, E. J., Plasma and dietary vitamin E in relation to insulin secretion and sensitivity. Diabetes Obes. Metab. 2008, 10, 223-228.
54. Manning, P. J., Sutherland, W. H., Walker, R. J., Williams, S. M. et al., Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004, 27, 2166-2171.
55. Montonen, J., Knekt, P., Jarvinen, R., Reunanen, A., Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27, 362-366.
56. Laight, D. W., Desai, K. M., Gopaul, N. K., Anggard, E. E. et al., F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur. J. Pharmacol. 1999, 377, 89-92.
57. Ihara, Y., Yamada, Y., Toyokuni, S., Miyawaki, K. et al., Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 2000, 473, 24-26.
58. Faure, P., Rossini, E., Lafond, J. L., Richard, M. J. et al., Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J. Nutr. 1997, 127, 103-107.
59. Rasekhi, H., Karandish, M., Jalali, M. T., Mohammadshahi, M. et al., Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. J. Diabetes Metab. Disord. 2015, 14, 1-6.
60. Choi, H. J., Yu, J., Choi, H., An, J. H. et al., Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011, 34, e147.
61. Knapen, M. H., Schurgers, L. J., Shearer, M. J., Newman, P. et al., Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight. Br. J. Nutr. 2012, 108, 1017-1024.
62. Landrier, J. F., Marcotorchino, J., Tourniaire, F., Lipophilic micronutrients and adipose tissue biology. Nutrients 2012, 4, 1622-1649.
63. Tourniaire, F., Gouranton, E., von Lintig, J., Keijer, J. et al., beta-Carotene conversion products and their effects on adipose tissue. Genes Nutr. 2009, 4, 179-187.
64. Bonet, M. L., Canas, J. A., Ribot, J., Palou, A., Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch. Biochem. Biophys. 2015, 572, 112-125.
65. Zhang, Y., Matheny, M., Zolotukhin, S., Tumer, N. et al., Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim. Biophys. Acta 2002, 1584, 115-122.
66. Cisneros, F. J., Gough, B. J., Patton, R. E., Ferguson, S. A., Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid. J. Appl. Toxicol. 2005, 25, 470-478.
67. Gouranton, E., Aydemir, G., Reynaud, E., Marcotorchino, J. et al., Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. Biochim. Biophys. Acta 2011, 1811, 1105-1114.
68. Koistinen, H. A., Remitz, A., Koivisto, V. A., Ebeling, P., Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic. Diabetologia 2006, 49, 383-386.
69. Heliovaara, M. K., Remitz, A., Reitamo, S., Teppo, A. M. et al., 13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration. Metabolism 2007, 56, 786-791.
70. Kameji, H., Mochizuki, K., Miyoshi, N., Goda, T., beta-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-alpha. Nutrition 2010, 26, 1151-1156.
71. Amengual, J., Gouranton, E., van Helden, Y. G., Hessel, S. et al., Beta-carotene reduces body adiposity of mice via BCMO1. PLoS One 2011, 6, e20644.
72. Ziouzenkova, O., Orasanu, G., Sukhova, G., Lau, E. et al., Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses. Mol. Endocrinol. 2007, 21, 77-88.
73. Kawada, T., Aoki, N., Kamei, Y., Maeshige, K. et al., Comparative investigation of vitamins and their analogues on terminal differentiation, from preadipocytes to adipocytes, of 3T3-L1 cells. Comp. Biochem. Physiol. A 1990, 96, 323-326.
74. Ben Amara, N., Tourniaire, F. Maraninchi, M., Attia, N. et al., Independent positive association of plasma beta-carotene concentrations with adiponectin among non-diabetic obese subjects. Eur. J. Nutr. 2015, 54, 447-454.
75. Suzuki, K., Inoue, T., Hashimoto, S., Ochiai, J. et al., Association of serum carotenoids with high molecular weight adiponectin and inflammation markers among Japanese subjects. Clin. Chim. Acta 2010, 411, 1330-1334.
76. Iwamoto, M., Imai, K., Ohta, H., Shirouchi, B. et al., Supplementation of highly concentrated beta-cryptoxanthin in a satsuma mandarin beverage improves adipocytokine profiles in obese Japanese women. Lipids Health Dis. 2012, 11, 52-56.
77. Hu, X., Li, Y., Li, C., Fu, Y. et al., Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat diet-induced obese rats. Arch. Biochem. Biophys. 2012, 519, 59-65.
78. Goto, T., Takahashi, N., Kato, S., Kim, Y. I. et al., Bixin activates PPARalpha and improves obesity-induced abnormalities of carbohydrate and lipid metabolism in mice. J. Agric. Food Chem. 2012, 60, 11952-11958.
79. Hussein, G., Nakagawa, T., Goto, H., Shimada, Y. et al., Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci. 2007, 80, 522-529.
80. Yoshida, H., Yanai, H., Ito, K., Tomono, Y. et al., Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010, 209, 520-523.
81. Marcotorchino, J., Romier, B., Gouranton, E., Riollet, C. et al., Lycopene attenuates LPS-induced TNF-alpha secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol. Nutr. Food Res. 2012, 56, 725-732.
82. Gouranton, E., Thabuis, C., Riollet, C., Malezet-Desmoulins, C. et al., Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J. Nutr. Biochem. 2011, 22, 642-648.
83. Luvizotto, R., Nascimento, A., Miranda, N., Wang, X. D. et al., Lycopene-rich tomato oleoresin modulates plasma adiponectin concentration and mRNA levels of adiponectin, SIRT1, and FoxO1 in adipose tissue of obese rats. Hum. Exp. Toxicol. 2015, 34, 612-619.
84. Aydemir, G., Kasiri, Y., Birta, E., Beke, G. et al., Lycopene-derived bioactive retinoic acid receptors/retinoid-X receptors-activating metabolites may be relevant for lycopene's anti-cancer potential. Mol. Nutr. Food Res. 2013, 57, 739-747.
85. Gijsbers, L., van Eekelen, H. D., de Haan, L. H., Swier, J. M. et al., Induction of peroxisome proliferator-activated receptor gamma (PPARgamma)-mediated gene expression by tomato (Solanum lycopersicum L.) extracts. J. Agric. Food. Chem. 2013, 61, 3419-3427.
86. Vaidya, A., Williams, J. S., Forman, J. P., The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity 2012, 20, 186-191.
87. Bidulescu, A., Morris, A. A., Stoyanova, N., Meng, Y. X. et al., Association between vitamin D and adiponectin and its relationship with body mass index: the META-Health Study. Front. Public Health 2014, 2, 193-199.
88. Gannage-Yared, M. H., Chedid, R., Khalife, S., Azzi, E. et al., Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur. J. Endocrinol. 2009, 160, 965-971.
89. Nimitphong, H., Chanprasertyothin, S., Jongjaroenprasert, W., Ongphiphadhanakul, B., The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009, 36, 205-210.
90. Liu, E., Meigs, J. B., Pittas, A. G., McKeown, N. M. et al., Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J. Nutr. 2009, 139, 329-334.
91. Husemoen, L. L., Skaaby, T., Martinussen, T., Jorgensen, T. et al., Investigating the causal effect of vitamin D on serum adiponectin using a Mendelian randomization approach. Eur. J. Clin. Nutr. 2014, 68, 189-195.
92. Sun, X., Morris, K. L., Zemel, M. B., Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: a microarray study. J. Nutrigenet. Nutrigenomics 2008, 1, 30-48.
93. Sergeev, I. N., Song, Q., High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol. Nutr. Food Res. 2014, 58, 1342-1348.
94. Marcotorchino, J., Tourniaire, F., Astier, J., Karkeni, E. et al., Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J. Nutr. Biochem. 2014, 25, 1077-1083.
95. Pittas, A. G., Dawson-Hughes, B., Vitamin D and diabetes. J. Steroid Biochem. Mol. Biol. 2010, 121, 425-429.
96. Lagishetty, V., Nandiwada, V. B., Kalashikam, R. R., Manchala, R., Effect of maternal vitamin and mineral restrictions on the body fat content and adipocytokine levels of WNIN rat offspring. Nutr. Metab. 2007, 4, 21-26.
97. Amara, N. B., Marcotorchino, J., Tourniaire, F., Astier, J. et al., Multivitamin restriction increases adiposity and disrupts glucose homeostasis in mice. Genes Nutr. 2014, 9, 410-418.
98. Vincent, H. K., Bourguignon, C. M., Weltman, A. L., Vincent, K. R. et al., Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 2009, 58, 254-262.
99. Ristow, M., Zarse, K., Oberbach, A., Kloting, N. et al., Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. U S A 2009, 106, 8665-8670.
100. Mantzoros, C. S., Williams, C. J., Manson, J. E., Meigs, J. B. et al., Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr. 2006, 84, 328-335.
101. Fragopoulou, E., Panagiotakos, D. B., Pitsavos, C., Tampourlou, M. et al., The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: the ATTICA study. J. Nutr. Biochem. 2010, 21, 285-289.
102. Romaguera, D., Norat, T., Mouw, T., May, A. M. et al., Adherence to the Mediterranean diet is associated with lower abdominal adiposity in European men and women. J. Nutr. 2009, 139, 1728-1737.
103. Bedard, A., Tchernof, A., Lamarche, B., Corneau, L. et al., Effects of the traditional Mediterranean diet on adiponectin and leptin concentrations in men and premenopausal women: do sex differences exist? Eur. J. Clin. Nutr. 2014, 68, 561-566.